DASH trial
Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage


ISRCTN 67038373
Room S/D2108, Stroke Trials Unit
School of Medicine, University of Nottingham
Queen's Medical Centre, Derby Road
Nottingham NG7 2UH, United Kingdom
The recruitment total for the trial to date is: 54

Login using the investigator ID, password and PIN issued to you by the DASH trial office.

If you have forgotten your login details then please click here.

DASH-1 is now closed to randomisation.
Please continue to enter follow-up data and SAEs for existing participants.

DASH investigator ID:
Password:
PIN:

Please ensure that your web browser has both cookies and JavaScript enabled.

NOTE:  Serious Adverse Events (SAEs) — we have a legal responsibility to collect all SAEs occurring within the first 7 days (including SARs/SUSARs).
Please remember that all fatal SAEs and safety outcome events – hyponatraemia (low sodium), hypervolaemia (fluid overload), seizures, VTE (DVT and/or PE), ischaemic stroke, TIA, MI/ACS and/or PAD – need to be reported, even those after the first 7 day period (until the final day 90 follow-up).
Please assess if expected according to SmPC: https://medicines.org.uk/emc/product/5447/smpc
Investigators have a legal responsibility to report applicable SAEs to the chief investigator within 24 hours.

Latest recruiting centres
University College Hospital, London, UK
Royal Victoria Infirmary, Newcastle upon Tyne, UK
Queens Medical Centre (UHN), Nottingham, UK
Aberdeen Royal Infirmary, Aberdeen, UK
St George's Hospital, London, UK
Royal Infirmary of Edinburgh, Edinburgh, UK
Royal Derby Hospital, Derby, UK
Royal Devon and Exeter Hospital (Wonford), Exeter, UK
Leicester Royal Infirmary, Leicester, UK
Royal Stoke University Hospital, Stoke-on-Trent, UK
 
Average time to randomisation (last 6 months)
# Hours Hospital
Documents